Can granulocyte-colony stimulating factor worsen anemia?

被引：1
作者：
Dang, Chau [1 ]
Hudis, Clifford [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 19期
关键词：
D O I：
10.1200/JCO.2006.06.1416
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2985 / 2986
页数：2
相关论文
共 7 条
[1]   Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy [J].
Burstein, HJ ;
Parker, LM ;
Keshaviah, A ;
Doherty, J ;
Partridge, AH ;
Schapira, L ;
Ryan, PD ;
Younger, J ;
Harris, LN ;
Moy, B ;
Come, SE ;
Schumer, ST ;
Bunnell, CA ;
Haldoupis, M ;
Gelman, R ;
Winer, EP .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8340-8347
[2]   Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].
Citron, ML ;
Berry, DA ;
Cirrincione, C ;
Hudis, C ;
Winer, EP ;
Gradishar, WJ ;
Davidson, NE ;
Martino, S ;
Livingston, R ;
Ingle, JN ;
Perez, EA ;
Carpenter, J ;
Hurd, D ;
Holland, JF ;
Smith, BL ;
Sartor, CI ;
Leung, EH ;
Abrams, J ;
Schilsky, RL ;
Muss, HB ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439
[3]  
DANG CT, CANC MED
[4]  
Hudis C, 2005, BREAST CANCER RES TR, V94, pS20
[5]   Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide? [J].
Papaldo, Paola ;
Ferretti, Gianluigi ;
Di Cosimo, Serena ;
Giannarelli, Diana ;
Marolla, Paolo ;
Lopez, Massimo ;
Cortesi, Enrico ;
Antimi, Mauro ;
Terzoli, Edmondo ;
Carlini, Paolo ;
Vici, Patrizia ;
Botti, Claudio ;
Di Lauro, Luigi ;
Naso, Giuseppe ;
Nistico, Cecilia ;
Mottolese, Marcella ;
Di Filippo, Franco ;
Ruggeri, Enzo Maria ;
Ceribelli, Anna ;
Cognetti, Francesco .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) :3048-3055
[6]   Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas:: results of the NHL-B1 trial of the DSHNHL [J].
Pfreundschuh, M ;
Trümper, L ;
Kloess, M ;
Schmits, R ;
Feller, AC ;
Rudolph, C ;
Reiser, M ;
Hossfeld, DK ;
Metzner, B ;
Hasenclever, D ;
Schmitz, N ;
Glass, B ;
Rübe, C ;
Loeffler, M .
BLOOD, 2004, 104 (03) :626-633
[7]   Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:: results of the NHL-B2 trial of the DSHNHL [J].
Pfreundschuh, M ;
Trümper, L ;
Kloess, M ;
Schmits, R ;
Feller, AC ;
Rübe, C ;
Rudolph, C ;
Reiser, M ;
Hossfeld, DK ;
Eimermacher, H ;
Hasenclever, D ;
Schmitz, N ;
Loeffler, M .
BLOOD, 2004, 104 (03) :634-641
1